Breast Cancer Screening Market Future Scenario and Growth Statistics Up to 2027 | BD, MYRIAD GENETICS, SIEMENS HEALTHCARE, Exact Sciences

The Insight Partners analysts forecasts the latest report on “Breast Cancer Screening Market (Covid-19) Impact and Analysis by 2027”, according to report; the Breast Cancer Screening Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Breast Cancer Screening Market.

The study provides details such as the market share, Market Insights, Strategic Insights, Segmentation and key players in the Breast Cancer Screening Market.

Download Sample Report of Breast Cancer Screening Market Report @
https://www.theinsightpartners.com/sample/TIPRE00009796/?openpr-10203

The global breast cancer screening market is expected to reach US$ 6,209.25 Mn by 2027 from US$ 4,638.63 Mn in 2019; it is estimated to grow at a CAGR of 4.8% from 2020 to 2027.

Some of the Major Market Players Are:

Koninklijke Philips N.V.., HOLOGIC, INC., BD, MYRIAD GENETICS, INC., SIEMENS HEALTHCARE GMBH, Exact Sciences Corporation, ONCOCYTE CORPORATION, POC MEDICAL SYSTEMS, Danaher, GENERAL ELECTRIC

Market Insights

Breast cancer is among the prime causes of deaths in the world, and it is profoundly affecting the quality of life. Thus, it acts as a burden on society if not diagnosed and treated on time. As per the estimations by the American Cancer Society, breast cancer is the most common type of cancer in the US as it caused morbidity in ~234,087 people and lead to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, and around the disease lead to ~19,376 deaths in that year. Further, as per the Globocan report, in 2018, there were ~367,900 new cases of breast cancer and 97,972 deaths due to the same in China.

In India, NGOs, government agencies, and charity organizations are emphasizing on breast cancer awareness among population to promote early detection, provide comprehensive treatment module, and extend support for breast cancer management. Such initiatives are a result of the increasing prevalence of this type of cancer in the country. As per the Globocan report estimation, in 2018, India reported ~162,468 new breast cancer cases and 87,090 deaths due to the same. Such growing prevalence of breast cancer in different regions around the world is raising the global demand for the screening devices for the same.

Test Type-Based Market Insights

The breast cancer screening market, by product type, is segmented into blood marker tests, imaging test, genetic test, immunohistochemistry test. The imaging test segment held the largest share of the market in 2019, and it is also anticipated to register the highest CAGR in the market during the forecast period.

End-User-Based Insights

On the basis of end user, the breast cancer screening market has been segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019, whereas the diagnostic centers segment is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Product launches and approvals is a commonly adopted strategy by companies in the breast cancer screening market to expand their footprint worldwide and meet the growing demand by enlarging their product portfolios. They also adopt the strategy of expansion to enlarge customer base across the world, which also permits them to maintain their brand name globally. For instance, in June 2017, Siemens Healthineers received Food and Drug Administration (FDA) approval of product namely syngo.via VB20 which is likely to use for for Molecular Imaging (MI) from Siemens Healthineers — a new release of the company’s established intelligent visualization software for multi-modality imaging.

Market Segmentation Analysis:

Breast Cancer Screening Market – By Product Type

• Blood Marker Test
• Imaging Test
• Genetic Test
• Immunohistochemistry Test

Breast Cancer Screening Market – By Application

• Diagnostic Centers
• Hospitals
• Research Laboratories
• Cancer Institutes

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Major Features of Breast Cancer Screening Market Report:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Breast Cancer Screening market

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global Breast Cancer Screening market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Purchase a copy of Breast Cancer Screening Market research report @ https://www.theinsightpartners.com/buy/TIPRE00009796/?openpr-10203

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.